In o-WAT, mast cells of patients with T2D have a decrease in the surface expression of CD45 (p=0.0013), CD117 (p=0.0066), CD203c (p=0.0025), and FcεRI (p=0.043). This evidence concerns the gene KIT and type 2 diabetes mellitus.